Stay updated on Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial
Sign up to get notified when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.

Latest updates to the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision updated from v3.6.4 to v3.6.5, indicating a minor update to the page’s version or metadata without altering study content.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a newer version of the page documentation. This update does not modify study details or functionality.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page revision label was updated to v3.6.3, replacing the previous v3.6.2. This appears to be a minor maintenance update and does not alter study details.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision tag updated to v3.6.2, replacing v3.6.0, signaling a minor page update. The core study details and data on the page appear unchanged.SummaryDifference0.1%

- Check70 days agoChange DetectedA recruitment-closed notice has been added, and new help sections such as 'How to Read a Study Record' and 'How to Join a Study' have been introduced to assist visitors.SummaryDifference0.5%

- Check77 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, signaling a minor administrative update to the study record metadata. No substantive content, criteria, or results have changed.SummaryDifference0.1%

Stay in the know with updates to Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.